Association between anxiety, depression, and comorbid chronic diseases among cancer survivors

2019 ◽  
Vol 28 (6) ◽  
pp. 1269-1277 ◽  
Author(s):  
Rui Yan ◽  
Juan Xia ◽  
Renren Yang ◽  
Binghui Lv ◽  
Peng Wu ◽  
...  
Keyword(s):  
Cancer Survivors ◽  
Chronic Diseases ◽  
Comorbid Chronic Diseases ◽  
Anxiety Depression

The influence of comorbid chronic diseases and physical activity on quality of life in lung cancer survivors

2014 ◽  
Vol 23 (5) ◽  
pp. 1383-1389 ◽  
Author(s):  
Ji-Wei Wang ◽  
Xiong-Huan Gong ◽  
Ning Ding ◽  
Xue-Fen Chen ◽  
Li Sun ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Physical Activity ◽  
Lung Cancer ◽  
Cancer Survivors ◽  
Chronic Diseases ◽  
Comorbid Chronic Diseases

scholarly journals Anxiety and Depression among Hypertensive Outpatients in Afghanistan: A Cross-Sectional Study in Andkhoy City

2018 ◽  
Vol 2018 ◽  
pp. 1-8 ◽  
Author(s):  
Mohammad Shoaib Hamrah ◽  
Mohammad Hassan Hamrah ◽  
Hideki Ishii ◽  
Susumu Suzuki ◽  
Mohammad Hussain Hamrah ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Chronic Diseases ◽  
National Level ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Depression Symptoms ◽  
Cross Sectional ◽  
Hypertensive Patients ◽  
Comorbid Anxiety ◽  
Anxiety Depression

There is a relationship between mental and physical health. Depression and anxiety are linked with the development of several chronic diseases. The purpose of the present study was to determine the prevalence and factors associated with anxiety and depression among adult hypertensive outpatients in Afghanistan. Methods. Two hundred thirty-four consecutive hypertensive patients from December 2015 to August 2016 were recruited to complete the Hospital Anxiety and Depression Scale (HADS) questionnaire, which has scores for classifying the participants having anxiety and depression symptoms. Results. Of the total 234 patients, 81 (34.6%) were males and 153 (65.4%) were females. The mean age was 54.6±12.7 for the hypertensive patients with anxiety and 63.8±15.0 for the hypertensive patients with depression while this figure was 49.5±10.2 for the adult participants in general population in Kabul city (Saeed, 2013). The prevalence of anxiety and depression (42.3% vs. 58.1%) among hypertensive persons is compared with the same mental disorders among Afghan refugees (39.3% vs. 22.1%) in Dalakee Refugee Camp (in Iran) (Hosseini Divkolaye and Burkle, 2017). Of the total participants, 99 had anxiety (42.3%), 136 had depression (58.1%), and 66 had (28.2%) comorbid anxiety-depression. Multivariate analysis was used. For anxiety age, female gender, smoking, diabetes mellitus, and 2 or more chronic diseases had a significant association. For depression, age and diabetes mellitus had a significant association, and for comorbid anxiety, depression, age, diabetes mellitus, and 2 or more chronic diseases had a significant association. Conclusion. This study shows that anxiety and depression are highly prevalent among hypertensive patients in an outpatient clinic in Afghanistan. There was an association between some sociodemographic and clinical characteristics and anxiety and depression. More studies are needed on a national level to inform the development of strategies for the prevention and control of psychological distress among patients with chronic diseases in Afghanistan.

scholarly journals Characteristics of U.S. adults taking prescription antipsychotic medications, National Health and Nutrition Examination Survey 2013–2018

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Jeff A. Dennis ◽  
Lisaann S. Gittner ◽  
J. Drew Payne ◽  
Kenneth Nugent
Keyword(s):  
Chronic Diseases ◽  
National Health ◽  
Prescription Medications ◽  
Nutrition Examination Survey ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Antipsychotic Medications ◽  
Health And Nutrition ◽  
Comorbid Chronic Diseases ◽  
The U.S

Abstract Background Global 12-month psychosis prevalence is estimated at roughly 0.4%, although prevalence of antipsychotic use in the U.S. is estimated at roughly 1.7%. Antipsychotics are frequently prescribed for off label uses, but have also been shown to carry risk factors for certain comorbid conditions and with other prescription medications. The study aims to describe the socio-demographic and health characteristics of U.S. adults taking prescription antipsychotic medications, and to better understand the association of antipsychotic medications and comorbid chronic diseases. Methods The study pools 2013–2018 data from the National Health and Nutrition Examination Survey (NHANES), a nationally representative cross-sectional survey of non-institutionalized U.S. residents (n = 17,691). Survey staff record prescription medications taken within the past 30 days for each respondent, from which typical and atypical antipsychotic medications were identified. Results Prevalence of antipsychotic use among U.S. adults was 1.6% (n = 320). Over 90% of individuals taking antipsychotics reported having health insurance and a usual place for care, significantly more than their counterparts not taking antipsychotics. Further, those taking antipsychotics reported higher prevalence of comorbid chronic diseases and took an average of 2.3 prescription medications more than individuals not taking antipsychotics. Individuals taking antipsychotics were more likely to sleep 9 or more hours per night, be a current smoker, and have a body mass index greater than 30 kg/m2. Conclusions U.S. adults who take antipsychotic medications report more consistent health care access and higher prevalence of comorbid chronic diseases compared to those not taking antipsychotics. The higher comorbidity prevalence and number of total prescriptions highlight the need for careful assessment and monitoring of existing comorbidities and potential drug-drug interactions among adults taking antipsychotics in the U.S.

scholarly journals Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms

2019 ◽  
Vol 16 (12) ◽  
pp. 746-761 ◽  
Author(s):  
Cristina Renzi ◽  
Aradhna Kaushal ◽  
Jon Emery ◽  
Willie Hamilton ◽  
Richard D. Neal ◽  
...  
Keyword(s):  
Chronic Diseases ◽  
Cancer Diagnosis ◽  
Specific Effects ◽  
Underlying Mechanisms ◽  
Comorbid Chronic Diseases ◽  
Disease Specific

Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors

2014 ◽  
Vol 31 (7) ◽  
Author(s):  
Ahmet Alacacioglu ◽  
Eda Ulger ◽  
Umut Varol ◽  
Tugba Yavuzsen ◽  
Murat Akyol ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Testicular Cancer ◽  
Cancer Survivors ◽  
Sexual Satisfaction ◽  
Testicular Cancer Survivors ◽  
Anxiety Depression

Smoking and binge drinking among cancer survivors: The forth Korean national health and nutrition examination surveys (KNHANES IV, 2007-2009).

2012 ◽  
Vol 30 (4_suppl) ◽  
pp. 28-28
Author(s):  
Mi Ah Han ◽  
Myeung Guen Oh ◽  
Jong Park ◽  
So Yeon Ryu ◽  
Seong Woo Choi
Keyword(s):  
Cancer Survivors ◽  
Binge Drinking ◽  
Chronic Diseases ◽  
National Health ◽  
Smoking Rate ◽  
Control Groups ◽  
Cross Sectional ◽  
Health And Nutrition ◽  
History Of ◽  
History Of Cancer

28 Background: This study aimed to describe the prevalence of smoking and binge drinking among cancer survivors in Korea, and to compare these rates with those of two control groups: individuals without a history of cancer but with other chronic diseases, and individuals without a history of cancer and without other chronic diseases. Methods: The study is a cross-sectional analysis of 37,878 adults ≥20 years old who participated in the Forth Korean National Health and Nutrition Examination Surveys (KNHANES IV, 2007-2009). The prevalence of smoking and binge drinking were assessed and compared to two control groups. Logistic regression analyses were performed to determine the likelihood and predictors of current smoking and binge drinking. Results: The prevalence of smoking and binge drinking were 9.6% and 6.6% among cancer survivors, respectively. Cancer survivors showed lower smoking rate compared with both control groups after adjusting gender, age, marital status, education, income and health insurance. Survivors’ smoking and binge drinking did not vary substantially by the clinical factors assessed. Conclusions: In our study, the smoking rate was significantly low in cancer survivor compared with both control groups. This result suggested that cancer survivors were more likely than individuals without a cancer history to obtain good health related behavior.

Short-term effectiveness of a web-based tailored intervention for cancer survivors on quality of life, anxiety, depression, and fatigue: randomized controlled trial

2016 ◽  
Vol 26 (2) ◽  
pp. 222-230 ◽  
Author(s):  
Roy A. Willems ◽  
Catherine A. W. Bolman ◽  
Ilse Mesters ◽  
Iris M. Kanera ◽  
Audrey A. J. M. Beaulen ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Randomized Controlled Trial ◽  
Cancer Survivors ◽  
Controlled Trial ◽  
Tailored Intervention ◽  
Short Term ◽  
Web Based ◽  
Randomized Controlled ◽  
Anxiety Depression

scholarly journals A Smartphone App–Based Mindfulness Intervention for Cancer Survivors: Protocol for a Randomized Controlled Trial

10.2196/15178 ◽  
2020 ◽  
Vol 9 (5) ◽  
pp. e15178 ◽  
Author(s):  
Utkarsh B Subnis ◽  
Norman AS Farb ◽  
Katherine-Ann Laura Piedalue ◽  
Michael Speca ◽  
Sasha Lupichuk ◽  
...  
Keyword(s):  
Cancer Survivors ◽  
Primary Outcome ◽  
Controlled Trial ◽  
Cancer Recurrence ◽  
Fear Of Cancer Recurrence ◽  
Smartphone App ◽  
Cancer Treatments ◽  
Mindfulness Intervention ◽  
Fear Of Cancer ◽  
Anxiety Depression

Background Cancer patients transitioning to survivorship after completing cancer treatments need psychosocial interventions to manage stressors such as anxiety, depression, and fear of cancer recurrence. Mindfulness-based interventions (MBIs) are effective for treating these symptoms; however, cancer survivors are often unable to participate in face-to-face interventions because of difficulties such as work and family commitments, treatment-related side-effects, scheduling conflicts, and geography. Smartphone app–based MBIs are an innovative way to deliver psychosocial cancer care and can overcome several such difficulties, since patients can participate at their own convenience. Objective The SEAMLESS (Smartphone App–Based Mindfulness Intervention for Cancer Survivors) study aims to evaluate the efficacy of a tailored app-based mindfulness intervention for cancer survivors (the Am Mindfulness-Based Cancer Survivorship—MBCS—Journey) for treating (1) symptoms of stress (primary outcome), as well as (2) fear of cancer recurrence, anxiety, depression, fatigue, and overall physical functioning (secondary outcomes). This is the first Canadian efficacy trial of a tailored mindfulness app intervention in cancer survivors. Methods This is a randomized waitlist-controlled trial, which will evaluate the effectiveness of Am MBCS for impacting the primary and secondary outcomes in cancer survivors who have completed all their cancer treatments. Outcomes will be assessed using web-based surveys with validated psychometric instruments at (1) baseline, (2) mid-intervention (2 weeks later), (3) immediately postintervention (4 weeks), (4) 3 months postbaseline, (5) 6 months postbaseline, and (6) 12 months postbaseline. The waitlist group will complete all assessments and will cross over to the intervention condition after the 3-month assessment. In addition, data will be obtained by the smartphone app itself, which includes users’ engagement with the app-based intervention, their emotional state (eg, angry and elated) from a user-inputted digital emotion-mapping board, and psychobiometric data using photoplethysmography technology. Results The study received ethics approval in September 2018 and recruitment commenced in January 2019. Participants are being recruited through a provincial cancer registry, and the majority of participants currently enrolled are breast (44/83, 53%) or colorectal (17/83, 20%) cancer survivors, although some survivors of other cancer are also present. Data collection for analysis of the primary outcome time-point will be complete by September 2019, and the follow-up data will be collected and analyzed by September 2020. Data will be analyzed to determine group differences using linear mixed modelling statistical techniques. Conclusions Cancer care providers are uncertain about the efficacy of app-based mindfulness interventions for patients, which are available in great supply in today’s digital world. This study will provide rigorously evaluated efficacy data for an app-based mindfulness intervention for cancer survivors, which if helpful, could be made available for psychosocial care at cancer centers worldwide. Trial Registration ClinicalTrials.gov NCT03484000; https://clinicaltrials.gov/ct2/show/NCT03484000 International Registered Report Identifier (IRRID) DERR1-10.2196/15178

Sign in / Sign up

Export Citation Format

Share Document